Dr. Pablo Loarte-Campos will be presenting on the topic of "The Possible Role of SGLT-2 Inhibitors in the Treatment of New Onset Diabetes Mellitus after Transplant (NODAT)" on Friday, February 9. Dr. Loarte-Campos is a transplant nephrology fellow from the Albert Einstein College of Medicine in Bronx, New York. The seminar will be held in UAHS room 6302 at 8:00-9:00am. A continental breakfast will be provided.
More information on the event can be found here.